放射治疗后无进展的肝细胞癌：名称意味着什么？ - Suppr

Suppr

超能文献

Nonprogressing hepatocellular carcinoma after radiation therapy: What's in a name?

作者信息

Ronot Maxime

机构信息

Department of Radiology, Hopital Beaujon, APHP.Nord, Clichy, Université Paris Paris, CRI, INSERM 1149, Paris, France.

出版信息

Eur Radiol. 2025 Jul 10. doi: 10.1007/s00330-025-11784-x.

DOI:10.1007/s00330-025-11784-x

PMID:40637863

Abstract

摘要

相似文献

Nonprogressing hepatocellular carcinoma after radiation therapy: What's in a name?

Eur Radiol. 2025 Jul 10. doi: 10.1007/s00330-025-11784-x.

LI-RADS CT/MRI Radiation Treatment Response Algorithm Version 2024: Category Redistribution and Short-Term Outcomes in Patients Undergoing Y-90 Radioembolization for HCC.

AJR Am J Roentgenol. 2025 Apr 30. doi: 10.2214/AJR.25.32745.

Temporal evolution of the LI-RADS radiation treatment response assessment on multiphase CT/MRI in patients undergoing selective internal radiation therapy for hepatocellular carcinoma.

Eur Radiol. 2025 May 17. doi: 10.1007/s00330-025-11659-1.

PGT-A: what's it for, what's wrong?

J Assist Reprod Genet. 2025 Jan;42(1):63-69. doi: 10.1007/s10815-025-03400-0. Epub 2025 Jan 23.

Health Inequalities, Disparities, Equity: What's in a Name?

Am J Public Health. 2025 Jul;115(7):996-1002. doi: 10.2105/AJPH.2025.308062.

Diabetes, What's in a Name? Diabetes Diagnosis and Classification.

Home Healthc Now. 2024;42(1):52. doi: 10.1097/NHH.0000000000001234.

Discomfort or pain: what's in a name?

Gut. 2024 Sep 9;73(10):e20. doi: 10.1136/gutjnl-2023-331775.

Coronary chronic total occlusions: What's in a name and how do we treat it?

Rev Port Cardiol. 2025 Jul;44(7):441-443. doi: 10.1016/j.repc.2025.05.004. Epub 2025 May 31.

Competing risks analysis of external versus internal radiation in patients with hepatocellular carcinoma after controlling for immortal time bias.

J Cancer Res Clin Oncol. 2023 Sep;149(12):9927-9935. doi: 10.1007/s00432-023-04915-8. Epub 2023 May 30.

Breast intensity modulated radiation therapy versus tissue compensation: what's in a name?

Pract Radiat Oncol. 2014 Jan-Feb;4(1):3-5. doi: 10.1016/j.prro.2013.02.010. Epub 2013 Apr 16.

本文引用的文献

Prognostic value of early response in predicting survival in hepatocellular carcinoma patients treated with selective internal radiation therapy.

Eur Radiol. 2025 Jun;35(6):3181-3191. doi: 10.1007/s00330-024-11253-x. Epub 2024 Dec 19.

CT/MRI LI-RADS 2024 Update: Treatment Response Assessment.

Radiology. 2024 Nov;313(2):e232408. doi: 10.1148/radiol.232408.

LI-RADS Treatment Response Algorithm: Performance and Diagnostic Accuracy With Radiologic-Pathologic Explant Correlation in Patients With SBRT-Treated Hepatocellular Carcinoma.

Int J Radiat Oncol Biol Phys. 2022 Mar 1;112(3):704-714. doi: 10.1016/j.ijrobp.2021.10.006. Epub 2021 Oct 10.

mRECIST for HCC: Performance and novel refinements.

J Hepatol. 2020 Feb;72(2):288-306. doi: 10.1016/j.jhep.2019.09.026.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Nonprogressing hepatocellular carcinoma after radiation therapy: What's in a name?

作者信息

Ronot Maxime

机构信息

Department of Radiology, Hopital Beaujon, APHP.Nord, Clichy, Université Paris Paris, CRI, INSERM 1149, Paris, France.

出版信息

Eur Radiol. 2025 Jul 10. doi: 10.1007/s00330-025-11784-x.

DOI:10.1007/s00330-025-11784-x

PMID:40637863

Abstract

摘要

相似文献

Nonprogressing hepatocellular carcinoma after radiation therapy: What's in a name?

Eur Radiol. 2025 Jul 10. doi: 10.1007/s00330-025-11784-x.

LI-RADS CT/MRI Radiation Treatment Response Algorithm Version 2024: Category Redistribution and Short-Term Outcomes in Patients Undergoing Y-90 Radioembolization for HCC.

AJR Am J Roentgenol. 2025 Apr 30. doi: 10.2214/AJR.25.32745.

Temporal evolution of the LI-RADS radiation treatment response assessment on multiphase CT/MRI in patients undergoing selective internal radiation therapy for hepatocellular carcinoma.

Eur Radiol. 2025 May 17. doi: 10.1007/s00330-025-11659-1.

PGT-A: what's it for, what's wrong?

J Assist Reprod Genet. 2025 Jan;42(1):63-69. doi: 10.1007/s10815-025-03400-0. Epub 2025 Jan 23.

Health Inequalities, Disparities, Equity: What's in a Name?

Am J Public Health. 2025 Jul;115(7):996-1002. doi: 10.2105/AJPH.2025.308062.

Diabetes, What's in a Name? Diabetes Diagnosis and Classification.

Home Healthc Now. 2024;42(1):52. doi: 10.1097/NHH.0000000000001234.

Discomfort or pain: what's in a name?

Gut. 2024 Sep 9;73(10):e20. doi: 10.1136/gutjnl-2023-331775.

Coronary chronic total occlusions: What's in a name and how do we treat it?

Rev Port Cardiol. 2025 Jul;44(7):441-443. doi: 10.1016/j.repc.2025.05.004. Epub 2025 May 31.

Competing risks analysis of external versus internal radiation in patients with hepatocellular carcinoma after controlling for immortal time bias.

J Cancer Res Clin Oncol. 2023 Sep;149(12):9927-9935. doi: 10.1007/s00432-023-04915-8. Epub 2023 May 30.

Breast intensity modulated radiation therapy versus tissue compensation: what's in a name?

Pract Radiat Oncol. 2014 Jan-Feb;4(1):3-5. doi: 10.1016/j.prro.2013.02.010. Epub 2013 Apr 16.

本文引用的文献

Prognostic value of early response in predicting survival in hepatocellular carcinoma patients treated with selective internal radiation therapy.

Eur Radiol. 2025 Jun;35(6):3181-3191. doi: 10.1007/s00330-024-11253-x. Epub 2024 Dec 19.

CT/MRI LI-RADS 2024 Update: Treatment Response Assessment.

Radiology. 2024 Nov;313(2):e232408. doi: 10.1148/radiol.232408.

LI-RADS Treatment Response Algorithm: Performance and Diagnostic Accuracy With Radiologic-Pathologic Explant Correlation in Patients With SBRT-Treated Hepatocellular Carcinoma.

Int J Radiat Oncol Biol Phys. 2022 Mar 1;112(3):704-714. doi: 10.1016/j.ijrobp.2021.10.006. Epub 2021 Oct 10.

mRECIST for HCC: Performance and novel refinements.

J Hepatol. 2020 Feb;72(2):288-306. doi: 10.1016/j.jhep.2019.09.026.